PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Nov-2022 AbCellera Presents New Data on Further Development and Characterization of T-Cell Engager Platform at SITC 2022 Businesswire
10-Nov-2022 Aimmune Therapeutics to Present Positive Results from Phase 3 POSEIDON Study of PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] in Peanut-Allergic Children Aged 1 to 3 Years Businesswire
10-Nov-2022 Resource Label Group Acquires Scent Marketing Innovator Scentisphere® Businesswire
10-Nov-2022 White Oak Healthcare Finance Supports Multi-Site Acquisitions by United Dental Corporation Businesswire
10-Nov-2022 New Study Finds 85% of Aneurysms Identified by Viz™ ANEURYSM had not Been Referred for Neurovascular Review Businesswire
10-Nov-2022 TAE Life Sciences Announces Partnership with HDX Corporation for Launch of Boron Neutron Capture Therapy in South Korea Businesswire
10-Nov-2022 Horizon Therapeutics plc to Participate in Upcoming Investor Healthcare Conferences in November Businesswire
10-Nov-2022 Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy for Rheumatoid Arthritis at American College of Rheumatology Convergence 2022 Businesswire
10-Nov-2022 UroGen Pharma Reports Third Quarter 2022 Financial Results and Recent Corporate Developments Businesswire
10-Nov-2022 Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction Businesswire
10-Nov-2022 Wugen to Present at the Upcoming Jefferies London Healthcare Conference Businesswire
10-Nov-2022 Corner Therapeutics Debuts with Data Presentation on its Dendritic Cell Hyperactivation Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting Businesswire
10-Nov-2022 Flora Growth Announces Shareholders Owning Over 73% of Shares of Franchise Global Health Support Acquisition by Flora Businesswire
10-Nov-2022 Equillium Announces Initiation of Phase 2 study of EQ101 A First-in-Class Multi-Cytokine Inhibitor of IL-2, IL-9 and IL-15 Targeting Alopecia Areata Businesswire
10-Nov-2022 Harrow Launches Atropine.com Businesswire
10-Nov-2022 Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022 Businesswire
10-Nov-2022 PharmaSGP Holding SE raises forecast for FY 2022 PharmaSGP Holding SE
10-Nov-2022 Metal Nanoparticles Global Market Report 2022: Rising Focus of Governments on Nanotechnology Research Driving Growth - ResearchAndMarkets.com Businesswire
10-Nov-2022 Stoke Therapeutics to Host Webinar and Conference Call to Present Interim Data from the Phase 1/2a Studies of STK-001 in Children and Adolescents with Dravet Syndrome Businesswire
10-Nov-2022 Last-Mile Delivery Robot Global Market Report 2022: Growth of E-Commerce and Q-Commerce Industries Drive Sector - ResearchAndMarkets.com Businesswire